Shenzhen TargetRx, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Joint Venture
- Established
- 2014-08-04
- Employees
- 1
- Market Cap
- -
Clinical Trials
13
Active:4
Completed:4
Trial Phases
3 Phases
Phase 1:10
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (76.9%)Phase 2
2 (15.4%)Phase 3
1 (7.7%)TGRX-678 Pharmacokinetic Mass Balance
Phase 1
Not yet recruiting
- Conditions
- Chronic Myeloid Leukemia
- Interventions
- Drug: [14C]TGRX-678
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT06986772
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
TGRX-678 Phase I Oral Pharmacokinetic Study
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT06697899
- Locations
- 🇨🇳
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
Phase 1
Recruiting
- Conditions
- Hematologic MalignancyNon Small Cell Lung CancerAdvanced Solid Tumor
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06484816
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06453902
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
TGRX-326 Pharmacokinetic Mass Balance
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT06438367
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
- Prev
- 1
- 2
- 3
- Next
News
No news found